Primary Extranodal Lymphoma
1 clinical trials · Condition
◉ Watch Primary Extranodal Lymphoma
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Plus R-CHOP Regimen in Untreated Primary Extranodal DLBCL (NCT05093140) | Sun Yat-sen University | 2022-06-01 |
Track Primary Extranodal Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.